Xone Ceff S 500mg/250mg Injection is a sterile, injectable formulation combining Ceftriaxone sodium (500mg) and Sulbactam sodium (250mg), designed for the treatment of a broad spectrum of bacterial infections. Ceftriaxone, a third-generation cephalosporin antibiotic, exhibits potent bactericidal activity by inhibiting bacterial cell wall synthesis, thereby effectively targeting both Gram-positive and Gram-negative organisms. Sulbactam, a beta-lactamase inhibitor, enhances the efficacy of Ceftriaxone by preventing enzymatic degradation of the antibiotic, particularly against beta-lactamase producing resistant strains. This combination is indicated for the management of severe infections including lower respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and bone and joint infections. Xone Ceff S is administered via intramuscular or intravenous injection, with dosage and duration tailored according to the severity of infection and renal function status. The injection should be reconstituted and administered under strict aseptic conditions. Caution is advised in patients with known hypersensitivity to cephalosporins or penicillins. Adverse effects may include local injection site reactions, gastrointestinal disturbances, and hypersensitivity reactions. This combination offers a synergistic approach to combating resistant bacterial pathogens, ensuring effective clinical outcomes.